ROBERT CHAPDELAINE: Open Payments
NPI 1710080056 · PENNSVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 18 payments from 8 companies in 2025. Trend: 2023 $131 · 2024 $371 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 5 | $402 |
| Boston Scientific Corporation | 3 | $68 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
| Nalu Medical, Inc. | 2 | $50 |
| Abbott Laboratories | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Braeburn Inc. | 1 | $15 |
Products named: Senza, General - Pain Management, Belbuca, Nalu Neurostimulation System, ETERNA, VIVITROL, UBRELVY, BRIXADI.
Industry payments across NJ — which companies pay providers there.
